How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be?
Autor: | Han, Ru, Gomez, Jorge A., de Veras, Bruna, Pinto, Thatiana, Guzman-Holst, Adriana, Nieto, Javier, van Oorschot, Désirée A. M. |
---|---|
Zdroj: | Human Vaccines & Immunotherapeutics; 2023, Vol. 19 Issue 1, p1-14, 14p |
Databáze: | Complementary Index |
Externí odkaz: |